Retracted_article_on_dopaminergic_neurotoxicity_of_MDMAMDMA%E3%81%AE%E3%83%89%E3%83%BC%E3%83%91%E3%83%9F%E3%83%B3%E4%BD%9C%E5%8B%95%E6%80%A7%E7%A5%9E%E7%B5%8C%E6%AF%92%E6%80%A7%E3%81%AB%E3%81%A4%E3%81%84%E3%81%A6%E3%81%AE%E6%92%A4%E5%9B%9E%E3%81%95%E3%82%8C%E3%81%9F%E8%AB%96%E6%96%87%D0%9E%D1%82%D0%B7%D1%8B%D0%B2_%D1%81%D1%82%D0%B0%D1%82%D1%8C%D0%B8_%D0%BE_%D0%B4%D0%BE%D1%84%D0%B0%D0%BC%D0%B8%D0%BD%D0%B5%D1%80%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%B9_%D0%BD%D0%B5%D0%B9%D1%80%D0%BE%D1%82%D0%BE%D0%BA%D1%81%D0%B8%D1%87%D0%BD%D0%BE%D1%81%D1%82%D0%B8_MDMAQ1964440
about
sameAs
MDMA and the “Ecstasy Paradigm”Baboon carboxylesterases 1 and 2: sequences, structures and phylogenetic relationships with human and other primate carboxylesterasesNeuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.How Drug Control Policy and Practice Undermine Access to Controlled Medicines.Realities at the leading edge of research.The impact of positive and negative ecstasy-related information on ecstasy use among college students: Results of a longitudinal studyAcute toxic effects of club drugs.The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaquesManganese-Induced Parkinsonism due to Ephedrone AbuseMonoamine reuptake inhibitors in Parkinson's disease.Obesity, diabetes and other problems.Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.Party drugs: properties, prevalence, patterns, and problems.Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat.Science forced to retract article on "ecstasy".When to retract?Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.Psychedelic drugs: the ups and downs of ecstasy.Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities.Progress and promise for the MDMA drug development program.Effects of Schedule I drug laws on neuroscience research and treatment innovation.Acute amnestic syndrome due to MDMA exposure.The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA.Chronic administration of amphetamines disturbs development of neural progenitor cells in young adult nonhuman primates.Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
P2860
Q21558618-C022C9DF-A8E9-435D-98E4-414EB7429172Q28751855-AD3812BB-25B5-4546-8D00-D3F1BE83F7EAQ31033312-0EE8DF1F-1F1F-4B59-A731-1367E5A5EAA7Q33805755-1C97367A-DB8C-44C4-954C-01464FF4B22AQ34165979-E6D1C3AB-E7CE-433D-B0F6-BD36FE2AD806Q34271828-91D78C21-3B7D-4C02-901D-A828626D4125Q34370377-DF0300DA-6E29-472B-BCD4-BB7E60B617D2Q34502080-083E89B8-44A6-4D12-9012-1E9903F547B1Q34545356-1F4C92FE-3ACC-40FF-88EB-6BB740D591AFQ34552306-5E180D4E-64A0-4DBB-AF0E-B7B99057FAC9Q34595356-3EDB2498-AEB2-4F12-9EC8-64104616D176Q35165280-764FE3DE-7138-422F-87B8-2C8748C2BF10Q35619513-7C984143-C6C2-4EE9-B820-4D73B334ED42Q35950888-CA7E95DC-3A5C-4044-8FBA-F5546F99BF52Q35989723-ACF6ADD3-249D-4E2F-AF88-A4F41732E973Q36209983-8508F317-B5F9-4A75-88CD-3FF69E27A83FQ36875417-CED5D401-CFD9-445F-B956-C53BC9483E5FQ42253970-EE19CB2A-078B-4CA2-AB33-27C252D0B014Q42940852-7EAB144C-A3FE-4388-84D9-210770876646Q42972864-224CEABD-B916-472C-8954-9247BEF9DF54Q44394949-0F21A8BD-5B14-4347-9CF4-8F01824FD26CQ44407124-A59AAE15-43A1-438E-BB88-046EB7B9E435Q44811433-86E4485E-B725-4C21-A989-334ABE825525Q44894621-9E385260-A601-4FCC-84FD-BCAF5F065191Q45053012-52C0A8AA-2A5D-4927-B813-E7BB293E9ACDQ45106407-01194C83-F914-4695-BF99-FBB2E68A7F09Q47963200-B83A36F0-2352-4A4A-B347-3517E50171A4Q48463442-A0C0DC0E-D7AB-4D90-A0E6-80F99AE911ACQ48828319-873E5C1A-5AC8-49A2-A032-3B29A6004EFFQ50647145-28687DA5-338F-435C-B186-C77EEF7B7C0AQ51732157-5664D0D4-617D-4644-8202-F8D92BE75342Q52803481-670E2CF0-6AAF-4E89-8132-1826D7AF519A
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
MDMAのドーパミン作動性神経毒性についての撤回された論文
@ja
Retracted article on dopaminergic neurotoxicity of MDMA
@ast
Retracted article on dopaminergic neurotoxicity of MDMA
@en
Retracted article on dopaminergic neurotoxicity of MDMA
@en-gb
Retracted article on dopaminergic neurotoxicity of MDMA
@nl
Отзыв статьи о дофаминергической нейротоксичности MDMA
@ru
type
label
MDMAのドーパミン作動性神経毒性についての撤回された論文
@ja
Retracted article on dopaminergic neurotoxicity of MDMA
@ast
Retracted article on dopaminergic neurotoxicity of MDMA
@en
Retracted article on dopaminergic neurotoxicity of MDMA
@en-gb
Retracted article on dopaminergic neurotoxicity of MDMA
@nl
Отзыв статьи о дофаминергической нейротоксичности MDMA
@ru
altLabel
RETRACTED: Severe dopaminergic ...... e regimen of MDMA ("ecstasy").
@ast
RETRACTED: Severe dopaminergic ...... e regimen of MDMA ("ecstasy").
@en
Severe dopaminergic neurotoxic ...... e regimen of MDMA ("ecstasy").
@en
Severe dopaminergic neurotoxic ...... reational dose regimen of MDMA
@nl
prefLabel
MDMAのドーパミン作動性神経毒性についての撤回された論文
@ja
Retracted article on dopaminergic neurotoxicity of MDMA
@ast
Retracted article on dopaminergic neurotoxicity of MDMA
@en
Retracted article on dopaminergic neurotoxicity of MDMA
@en-gb
Retracted article on dopaminergic neurotoxicity of MDMA
@nl
Отзыв статьи о дофаминергической нейротоксичности MDMA
@ru
P50
P356
P1433
P1476
RETRACTED: Severe dopaminergic ...... e regimen of MDMA ("ecstasy").
@en
P2093
George Hatzidimitriou
P304
P356
10.1126/SCIENCE.1074501
P407
P577
2002-09-27T00:00:00Z